Earthtimes.orgECB makes new cash injection ahead of rate decisionTimes Online, UK - 8 hours agoThe ECB announced the new cash injection as evidence emerged stability was returning to some parts of the bond markets when AstraZeneca, the drugs giant, …ECB moves again to shore up market confidence EUX.TVall 6 news articles
Read full story
AstraZeneca Announces First Patient Enrolled in Head-to-Head …news aktuell (Pressemitteilung), Germany - 2 hours agoLondon (ots/PRNewswire) - AstraZeneca today announced enrolment of the first patient in the new GRAVITY study (Gauging the lipid effects of RosuvAstatin …
Read full story
AstraZeneca sells $6.9 billion of debt for MedImmuneThe News Journal, DE - 1 hour agoBy ANDREA GERLIN, Bloomberg AstraZeneca Plc, the UK's second largest drugmaker, sold $6.9 billion in bonds to fund the purchase of US biotechnology company …Blyth Joins HSBC Holdings Wall Street Journalall 2 news articles
Read full story
AstraZeneca cuts through volatility with $7bn bond sale Duncan KerrFinancial News Online US, UK - 2 hours agoPharmaceutical company AstraZeneca yesterday returned to the primary debt market for the first time in over three years to successfully sell close to $7bn …For AstraZeneca at least, the cost of money is going up FT Alphavilleall 2 news articles
Read full story
Biovator and AstraZeneca Join Forces to Launch a New Alternative …Business Wire (press release), CA - 6 hours agoFor several years Biovator, often with support from AstraZeneca, has been refining an in Vitro method to take the place of expensive and ethically …
Read full story
AstraZeneca launches and prices 6.9 bln usdHemscott, UK - 10 hours agoLONDON (Thomson Financial) - AstraZeneca PLC has launched and priced a 6.9 bln usd bond issue, saying it will use the proceeds to repay a significant …
Read full story
Gulf NewsAstraZeneca considers euro bond sale -bankReuters.uk, UK - 7 hours agoAstraZeneca is rated A1 by Moody's Investors Service and AA- by Standard & Poor's. On Wednesday, AstraZeneca priced $6.9 billion of bonds to repay a …AstraZeneca Launches and Prices a $6.9 Billion Bond Issue PharmaLive.com (press release)AstraZeneca's Iressa matches chemo in lung cancer Reuters.ukAstraZeneca says no big shift on India patent case Reuters.ukReuters - Reutersall 18 news articles
Read full story
AstraZeneca forms partnership with Peking University HospitalMarketWatch - Sep 4, 2007By MarketWatch LONDON (MarketWatch) — AstraZeneca Tuesday announced a strategic partnership with Peking University 3rd Hospital to open its first Clinical …AstraZeneca signs China deal to speed up drug development Pharma Times (subscription)AstraZeneca establishes the 1st clinical pharmacology unit in China CCTVAstraZeneca to open China unit The News JournalFDA news (subscription)all 7 news articles
Read full story
AstraZeneca and Peking University partner to speed up drug …Interfax.cn (subscription), China - 12 hours agoINTERFAX-CHINA - Anglo-Swedish pharmaceutical company AstraZeneca announced on Tuesday in Beijing a strategic partnership with Peking University Third …
Read full story
Dog Flu Diet and DiseasesAtheroGenics Cites Possible AGI-1067 UseForbes, NY - 3 hours agoThat prompted partner AstraZeneca PLC (nyse: AZN - news - people ) to end its collaboration with the company. AtheroGenics (nasdaq: AGIX - news - people …Failed AtheroGenics Drug Benefits Diabetes Patients Dog Flu Diet and DiseasesFailed AtheroGenics drug has small diabetes effect Reuters.ukAtheroGenics drug may help fight diabetes Bizjournals.comall 17 news articles
Read full story
Morello from Mediasurface chosen by AstraZeneca as its Global Web …SourceWire (press release), UK - Sep 4, 20074 September 2007 – Morello by Mediasurface has been chosen by AstraZeneca, one of the world’s leading pharmaceutical companies, as the sole platform of …
Read full story
Pharmaceutical firm streamlines content managementVNUNet.com, UK - Sep 4, 2007AstraZeneca is putting in a single global web content mangement platform to replace multiple existing systems. The new system called Morello, …
Read full story
AstraZeneca's Iressa matches chemo in lung cancerReuters - 8 hours agoAstraZeneca once hoped the drug would be a "blockbuster" — making over $1 billion of sales a year. But forecasts were pared back when it failed a key …
Read full story
Abbott, AstraZeneca Advance Study of Cholesterol Pill (Update2)Bloomberg - Aug 31, 200731 (Bloomberg) — Abbott Laboratories and AstraZeneca Plc will start advanced trials on a drug that would raise good cholesterol and lower bad to compete …
Read full story
Abbott-AstraZeneca Pill AdvancesForbes, NY - Aug 31, 2007AP 08.31.07, 10:53 AM ET Diversified health care products maker Abbott Laboratories and British drug maker AstraZeneca PLC said Friday they plan to begin …
Read full story
Abbott, AstraZeneca Advance Study of Cholesterol Pill (Update1)Bloomberg - Aug 31, 200731 (Bloomberg) — Abbott Laboratories and AstraZeneca Plc confirmed they will begin advanced studies of a single pill to lower bad cholesterol, …
Read full story
Telegraph.co.ukAbolish NHS, says Brown's 'wise man'Telegraph.co.uk, United Kingdom - 17 hours agoBy Edmund Conway, Economics Editor An influential former Bank of England executive has called on Prime Minister Gordon Brown to abolish the National Health …Drugs industry welcomes NHS research reforms Financial Times (subscription)Families in Future Healthcare Plight ITNewsall 4 news articles
Read full story
AstraZeneca supports uninsured kids and familiesThe News Journal, DE - Sep 1, 2007Last month, AstraZeneca pledged support to "Delaware Covering Kids and Families," a collaborative effort run by the Medical Society of Delaware that …
Read full story
AstraZeneca says Netherlands approves Seroquel XRReuters - Aug 29, 2007Seroquel is AstraZeneca's second-biggest drug, with global sales of $3.4 billion last year. AstraZeneca said in a statement that it would proceed with a …
Read full story
Personnel Today Awards 2007: Computers In Personnel Award for …PersonnelToday.com, UK - 3 hours agoAstraZeneca is a pharmaceutical company that develops, manufactures and markets medicines. The company operates in more than 100 countries and employs about …
Read full story